With a slew of new GLP-1 indications approved in recent history, researchers and experts are now diving into their use in treating substance use disorders.
Sylvie Stacy, MD, MPH
Advertisement
Sylvie Stacy, MD, MPH, Chief Medical Officer for Rehab.com
Articles by Sylvie Stacy, MD, MPH
In part 2, Sylvie Stacy, MD, MPH, explores the current evidence regarding GLP-1s for SUD, the work still necessary in the future of this space, and where pharmacists fall within it all.
Sylvie Stacy, MD, MPH, introduces her work on GLP-1s for addiction and the new pathways this drug class can introduce for patients living with SUD.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
How Pharmacists Take Control of Medical Billing
2
Data Show Rise in GLP-1 Poison Center Calls Tied to Dosing Errors
3
Lowered Pneumococcal Vaccination Age Has Yet to Close Awareness Gap
4
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol
5